Influenza Epidemic
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac (NCT03651544) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-10-15 |
Track Influenza Epidemic automatically
Every clearance here is in the API, with alerts when new ones post.